About
Shinobi Therapeutics develops immune-evasive induced pluripotent stem cell (iPSC) therapies designed to evade patient immune rejection, aiming to treat cancer and autoimmune diseases with advanced cell therapies.
Explore Shinobi Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.